Matthew S. Kelly
Section Chief, Infectious Diseases
Faculty Researcher
COM | Peds Infectious Diseases
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Matthew S. Kelly's research focuses on microbial communities and their role in human health, particularly in the context of infectious diseases and the immune response. He has investigated changes in the nasopharyngeal microbiome and their association with SARS-CoV-2 infection severity in children and adolescents. His work also includes exploring the potential of specific bacteria, such as *Dolosigranulum pigrum*, as nasal probiotics to reduce the risk of colonization by other pathogens, like *Streptococcus pneumoniae*.
Kelly also studies viral infections and vaccine efficacy. He has examined durable neutralizing antibody responses in children and adolescents following asymptomatic or mild SARS-CoV-2 infection and evaluated recombinant live-attenuated RSV vaccines in seronegative children. His research extends to other patient populations, including investigations into risk factors for CMV viremia and treatment-associated adverse events among pediatric hematopoietic stem cell transplant recipients.
With a career marked by extensive publications and citations, Kelly leads a research group at the University of Arkansas for Medical Sciences. His work contributes to understanding host-pathogen interactions, the impact of the microbiome on disease susceptibility, and the development of potential preventative strategies for infectious diseases.
Metrics
- h-index: 26
- Publications: 131
- Citations: 2,030
Selected Publications
-
Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis (2026)
-
Early life factors documented in electronic health records predict recurrent acute otitis media (2026)
-
Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them? (2026)
-
P-484. Global Economic Burden Of Pneumococcal Disease In Children — Lessons Learned From Economic Evaluations Of Pneumococcal Vaccines (2026)
-
Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 schedule (2025)
-
Pediatric T cell and B cell responses to SARS-CoV-2 infection (2025)
-
Alterations of the Upper Respiratory Microbiome Among Children Living With HIV Infection in Botswana (2025)
-
Corynebacterium rhinophilum sp. nov. isolated from the human upper respiratory tract (2025)
Collaboration Network
Top Collaborators
- P-484. Global Economic Burden Of Pneumococcal Disease In Children — Lessons Learned From Economic Evaluations Of Pneumococcal Vaccines
- Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them?
- P-484. Global Economic Burden Of Pneumococcal Disease In Children — Lessons Learned From Economic Evaluations Of Pneumococcal Vaccines
- Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis
- P-484. Global Economic Burden Of Pneumococcal Disease In Children — Lessons Learned From Economic Evaluations Of Pneumococcal Vaccines
- Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis
- P-484. Global Economic Burden Of Pneumococcal Disease In Children — Lessons Learned From Economic Evaluations Of Pneumococcal Vaccines
- Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
- Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
Similar Researchers
Based on overlapping research topics